Skip to main content

Diffusing Capacity and Mortality in Chronic Obstructive Pulmonary Disease.

Publication ,  Journal Article
Balasubramanian, A; Putcha, N; MacIntyre, NR; Jensen, RL; Kinney, G; Stringer, WW; Hersh, CP; Bowler, RP; Casaburi, R; Han, MK; Porszasz, J ...
Published in: Ann Am Thorac Soc
January 2023

Rationale: Chronic obstructive pulmonary disease (COPD) mortality risk is often estimated using the BODE (body mass index, obstruction, dyspnea, exercise capacity) index, including body mass index, forced expiratory volume in 1 second, dyspnea score, and 6-minute walk distance. Diffusing capacity of the lung for carbon monoxide (DlCO) is a potential predictor of mortality that reflects physiology distinct from that in the BODE index. Objectives: This study evaluated DlCO as a predictor of mortality using participants from the COPDGene study. Methods: We performed time-to-event analyses of individuals with COPD (former or current smokers with forced expiratory volume in 1 second/forced vital capacity < 0.7) and DlCO measurements from the COPDGene phase 2 visit. Cox proportional hazard methods were used to model survival, adjusting for age, sex, pack-years, smoking status, BODE index, computed tomography (CT) percent emphysema (low attenuation areas below -950 Hounsfield units), CT airway wall thickness, and history of cardiovascular or kidney diseases. C statistics for models with DlCO and BODE scores were used to compare discriminative accuracy. Results: Of 2,329 participants, 393 (16.8%) died during the follow-up period (median = 4.9 yr). In adjusted analyses, for every 10% decrease in DlCO percent predicted, mortality increased by 28% (hazard ratio = 1.28; 95% confidence interval, 1.17-1.41, P < 0.001). When compared with other clinical predictors, DlCO percent predicted performed similarly to BODE (C statistic DlCO = 0.68; BODE = 0.70), and the addition of DlCO to BODE improved its discriminative accuracy (C statistic = 0.71). Conclusions: Diffusing capacity, a measure of gas transfer, strongly predicted all-cause mortality in individuals with COPD, independent of BODE index and CT evidence of emphysema and airway wall thickness. These findings support inclusion of DlCO in prognostic models for COPD.

Duke Scholars

Published In

Ann Am Thorac Soc

DOI

EISSN

2325-6621

Publication Date

January 2023

Volume

20

Issue

1

Start / End Page

38 / 46

Location

United States

Related Subject Headings

  • Severity of Illness Index
  • Pulmonary Emphysema
  • Pulmonary Disease, Chronic Obstructive
  • Pulmonary Diffusing Capacity
  • Lung
  • Humans
  • Forced Expiratory Volume
  • Exercise Tolerance
  • Emphysema
  • Dyspnea
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Balasubramanian, A., Putcha, N., MacIntyre, N. R., Jensen, R. L., Kinney, G., Stringer, W. W., … McCormack, M. C. (2023). Diffusing Capacity and Mortality in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc, 20(1), 38–46. https://doi.org/10.1513/AnnalsATS.202203-226OC
Balasubramanian, Aparna, Nirupama Putcha, Neil R. MacIntyre, Robert L. Jensen, Gregory Kinney, William W. Stringer, Craig P. Hersh, et al. “Diffusing Capacity and Mortality in Chronic Obstructive Pulmonary Disease.Ann Am Thorac Soc 20, no. 1 (January 2023): 38–46. https://doi.org/10.1513/AnnalsATS.202203-226OC.
Balasubramanian A, Putcha N, MacIntyre NR, Jensen RL, Kinney G, Stringer WW, et al. Diffusing Capacity and Mortality in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2023 Jan;20(1):38–46.
Balasubramanian, Aparna, et al. “Diffusing Capacity and Mortality in Chronic Obstructive Pulmonary Disease.Ann Am Thorac Soc, vol. 20, no. 1, Jan. 2023, pp. 38–46. Pubmed, doi:10.1513/AnnalsATS.202203-226OC.
Balasubramanian A, Putcha N, MacIntyre NR, Jensen RL, Kinney G, Stringer WW, Hersh CP, Bowler RP, Casaburi R, Han MK, Porszasz J, Barr RG, Regan E, Make BJ, Hansel NN, Wise RA, McCormack MC. Diffusing Capacity and Mortality in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2023 Jan;20(1):38–46.

Published In

Ann Am Thorac Soc

DOI

EISSN

2325-6621

Publication Date

January 2023

Volume

20

Issue

1

Start / End Page

38 / 46

Location

United States

Related Subject Headings

  • Severity of Illness Index
  • Pulmonary Emphysema
  • Pulmonary Disease, Chronic Obstructive
  • Pulmonary Diffusing Capacity
  • Lung
  • Humans
  • Forced Expiratory Volume
  • Exercise Tolerance
  • Emphysema
  • Dyspnea